1. Three Different Transport Mechanisms
In desalting SEC, a macromolecular product is largely excluded from pores and elutes early while salts and other small solutes enter the beads and elute later. Dialysis allows permeable solutes to diffuse across a membrane toward equilibrium with an external reservoir. Ultrafiltration applies a pressure difference across a membrane: solvent and sufficiently permeable solutes pass, while retained macromolecule becomes concentrated; repeated or continuous replacement with new buffer produces diafiltration.
These descriptions assume no important adsorption, aggregation, membrane leakage, or specific solute binding. Real protein systems can deviate. A small molecule tightly bound to protein will not clear like free solute. A flexible protein may approach a membrane cutoff differently from a compact standard. Development must measure both product and the solute that controls success.
| Attribute | Desalting SEC | Dialysis | Ultrafiltration/diafiltration |
|---|---|---|---|
| Typical speed | Minutes to an hour per run | Hours or longer, depending on diffusion and exchanges | Minutes to hours, depending on area, pressure, flux, and volume |
| Product concentration | Often diluted by band volume | Usually similar unless osmotic or evaporative effects occur | Can be increased and controlled |
| Scale driver | Bed volume and allowable sample volume | Membrane area, reservoir volume, path length, and mixing | Membrane area, flux, hold-up, and concentration factor |
| Main failure risk | Overlap, dilution, adsorption, or wrong collection | Slow clearance, leakage, adsorption, or microbial/hold risk | Fouling, polarization, aggregation, leakage, or overconcentration |
2. Define the Decision Before Selecting Hardware
Specify starting and final volume, target concentration, current and required buffer, solutes to remove, acceptable residual level, required recovery, activity, temperature, maximum time, sterility or bioburden controls, available pressure, and downstream operation. Determine whether the step must concentrate, merely exchange, or also separate product-related size variants.
Estimate the size difference between target and permeating solutes, but do not reduce the decision to nominal molecular weight. Shape, hydration, charge, membrane or resin interaction, and protein association matter. Check whether the target dissociates into smaller subunits or whether a required cofactor, stabilizer, or ligand would be removed with the unwanted solute.
3. When Desalting SEC Is the Best Fit
Desalting is attractive when rapid processing and a sharp exchange from one small-solute environment to another are important. The medium is selected so the target is excluded or nearly excluded, whereas salts, imidazole, reducing agents, and other small compounds are substantially included. After equilibration in the desired buffer, the product emerges in an early fraction already surrounded by that buffer.
Load volume must remain within the validated operating window. Too much sample broadens the early zone and causes overlap with the salt front. Very concentrated or viscous samples can distort flow and peak shape. Collect fractions during development and assay target plus residual small solute. Expect some dilution; pool only the product-bearing early fractions. Explore size exclusion chromatography products when this mechanism fits.
4. When Dialysis Is the Best Fit
Dialysis is simple and gentle when the target is well retained and time is available. Exchange improves with membrane area, mixing on both sides, a short diffusion path, a large external-buffer volume, and repeated replacement of the reservoir. Each exchange approaches a new equilibrium; one long exposure to a saturated reservoir is less effective than planned buffer changes of appropriate volume.
Select membrane chemistry and MWCO using empirical retention, not a promise of absolute separation. Avoid overfilling a device because the surface-area-to-volume ratio and mixing affect time. Control temperature and sample hold. Recover material from corners and wet surfaces consistently, then rinse only if dilution is acceptable. Creative BioMart offers dialysis systems for evaluation.
5. When Ultrafiltration or Diafiltration Is the Best Fit
Ultrafiltration is useful when volume reduction and buffer exchange must be integrated. During concentration, permeable solutes leave with filtrate but remain in the retentate according to their passage and the changing volume. In diafiltration, fresh buffer is added while filtrate is removed, either continuously at constant retentate volume or through repeated concentration and redilution.
Flux usually declines as concentration polarization, viscosity, fouling, and osmotic pressure increase. Excess pressure may compact some membranes or intensify polarization rather than improve productivity. Mix or recirculate without damaging the protein, keep the membrane wetted, and stop at a validated concentration. Analyze permeate for product loss and retentate for aggregation and activity.
6. Predict and Measure Small-Solute Clearance
For ideal constant-volume diafiltration with a freely permeating solute, retentate concentration decreases approximately exponentially with the number of diavolumes: C/C0 ≈ e−N. This simple relation fails when the solute is partly retained, protein-bound, generated during the step, or when mixing is poor. For dialysis, mass balance and equilibrium across both compartments govern each exchange; repeated fresh reservoirs improve the driving force.
Desalting clearance is determined by chromatographic overlap and pooling, not an equilibrium formula. Measure conductivity only when it is a justified surrogate for the solute. Imidazole, detergents, cofactors, reducing agents, and mixed salts may require a specific assay. Always pair clearance with target recovery and final volume.
7. A Selection and Confirmation Workflow
- Define target retention, solute clearance, final concentration, time, and scale.
- Screen target stability in the destination buffer and at anticipated concentration.
- Choose one primary technology and one contingency based on mechanism.
- Run a small-scale mass balance with representative sample.
- Measure product in feed, recovered pool, membrane permeate, late SEC fractions, and device rinse as applicable.
- Measure the actual small solute, plus pH, conductivity, activity, aggregation, and volume.
- Optimize area or bed volume, load, exchange schedule, pressure, temperature, and collection.
- Confirm repeatability and the transition into the next step.
8. Application Examples
Rapid exchange after affinity elution
A small laboratory sample containing a high concentration of competitive eluent may suit desalting SEC if the target is much larger than the eluent and modest dilution is acceptable. Collect early fractions narrowly and move the product promptly into the next step.
Fragile multidomain protein
Dialysis may reduce shear and concentration stress, provided the protein remains stable during the longer hold. Use a conservative MWCO, adequate external buffer, mixing, and multiple exchanges. Check for loss to the membrane and device.
Large process pool requiring concentration
Diafiltration may combine exchange and volume reduction. Develop flux and recovery versus concentration, control temperature and pressure, define diavolumes from measured clearance, and establish a recovery procedure for system hold-up.
9. Scale and Control Strategy
Scale desalting by validated load fraction and bed geometry, dialysis by sample volume relative to effective membrane area and reservoir conditions, and ultrafiltration by membrane area, flux, mixing or crossflow, and concentration factor. Geometric similarity alone does not ensure the same mass transfer. Verify the controlling transport parameter and actual processing time.
For repeated or industrial use, define material compatibility, membrane integrity, cleaning or single-use handling, microbial control, maximum hold, temperature, buffer preparation, sampling, and disposal. Trend recovery, clearance, final volume, concentration, pressure or flux, and processing time. A change in one metric may predict a later product-quality failure.
10. Troubleshooting and Decision Record
| Problem | Possible explanation | Response |
|---|---|---|
| Residual small solute | Insufficient exchange, binding to protein, overlap, poor mixing, partial membrane retention | Measure specific solute; add exchanges or diavolumes; alter format |
| Low protein recovery | Adsorption, leakage, precipitation, late SEC collection, unrecovered hold-up | Analyze all streams; change material; improve recovery rinse or pool window |
| Unexpected dilution | Broad SEC pool, dialysis rinse, device hold-up, excessive diafiltration addition | Measure volumes by mass; tighten pooling; revise recovery |
| Aggregation | Unstable destination buffer, overconcentration, long hold, surface or shear stress | Run no-device stability control; reduce concentration or time; add compatible stabilizer |
| Slow processing | Low area, weak mixing, fouling, polarization, high viscosity, cold temperature | Increase effective area; improve mixing; lower concentration; optimize pressure |
Record why the selected technology fits the target, scale, clearance, concentration, and next step. Include membrane or medium identity, lot, buffer recipes, sample load, geometry, temperature, time, pressure or flow, exchange schedule, fraction definitions, recovery, residual solute, and product quality. State the conditions that would trigger a technology change—for example, scale, product concentration, instability, or an unacceptable solute-clearance requirement.
Do not compare methods using only processing time. Report hands-on time, total elapsed time, buffer use, number of transfers, concentration change, device hold-up, active recovery, and risk to the next operation. This whole-process comparison often changes the apparent winner.
11. Comparative Study and Technology-Transfer Checklist
When two technologies remain plausible, compare them with one starting pool and one destination buffer. Normalize the requested endpoint rather than the hardware: process each sample until it reaches the same residual-solute target. Record elapsed time, hands-on time, buffer consumption, number of transfers, final volume, concentration, active recovery, aggregation, and any product in discarded streams. This reveals whether speed or apparent simplicity hides a larger recovery or handling burden.
Use a no-device stability control held for the duration of the longest method. For dialysis, sample after each reservoir change; for diafiltration, sample by diavolume; for desalting, analyze consecutive fractions across the protein and small-solute boundary. A time course distinguishes slow transport from an unreachable endpoint caused by binding or partial retention.
Transfer the chosen method with a mechanism-based rule. For desalting, preserve medium, bed height, validated sample fraction, and flow basis. For dialysis, preserve effective membrane area per sample volume, reservoir ratio, mixing, temperature, and exchange schedule. For ultrafiltration, preserve membrane, area loading, concentration path, pressure or centrifugal condition, mixing, and diavolumes. Confirm device hold-up and recovery at the new scale.
The operating record should define incoming sample range, destination-buffer recipe, maximum hold, target and solute assays, acceptance criteria, recovery method, and response to leakage, low flux, poor clearance, or precipitation. Identify the contingency method. A small SEC desalting step may rescue a residual-solute failure after diafiltration; a concentration step may correct desalting dilution, but only if target stability has already been demonstrated.
Connect this guide to your purification project
Share the protein, sample volume and concentration, current and required buffer, scale, stability limits, target recovery, and analytical requirements. Our team can help evaluate media, dialysis formats, or a fit-for-purpose purification workflow.
References
- Hong P, Koza S, Bouvier ESP. Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J Liq Chromatogr Relat Technol. 2012;35:2923–2950.
- Erickson HP. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol Proced Online. 2009;11:32–51.
- Carta G, Jungbauer A. Protein Chromatography: Process Development and Scale-Up. 2nd ed. Wiley-VCH; 2020.
- Eskelin K, Oksanen HM. Isolating, culturing, and purifying viruses with a focus on bacterial and archaeal viruses. In: Encyclopedia of Virology. Elsevier; 2021:162-174.
